|
Market Cap (25-Jun) $3,159,507 (1,963rd) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 42,322 |
Shortsold (5-Apr) 9,554 (0.01%) (569th) |
|
52w High $0.020 |
52w Low $0.005 |
P/E - |
EPS -0.01 |
ANR released this announcement to the ASX on 18 November 2020, 8:52. The announcement is not marked as price sensitive, and is 2 page(s) in length and 187.16kb in size.
You can view all announcements from ANR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ANR was 0.003% short sold according to ASIC data. It was ranked the 598th most shorted stock on the ASX. It is now ranked as the 569th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (05 April 2024).
| Other Recent Announcements from ANR | |
|---|---|
| Anatara Update on GaRP Irritable Bowel Syndrome Trial | 6 June 2023, 8:19 |
| Anatara Investor Presentation | 8 May 2023, 10:44 |
| Registered Office Change | 20 April 2023, 11:51 |
| Anatara Animal Health Update | 18 November 2020, 8:52 |
| $1.4m raised through the completed SPP | 16 November 2020, 14:26 |
| Change in substantial holding - Tiga Trading Pty Ltd | 30 October 2020, 17:25 |
| Change in substantial holding from TEK | 30 October 2020, 17:23 |
You must be logged in to post a reply.
Anatara Lifesciences 